This is the authors' abstract. We don't add key points for this paper.
Proteasome-catalyzed peptide splicing (PCPS) generates peptides that are presented by MHC class I molecules, but because their identification is challenging, the immunological relevance of spliced peptides remains unclear. Here, we developed a reverse immunology-based multi-level approach to identify proteasome-generated spliced epitopes. Applying this strategy to a murine Listeria monocytogenes infection model, we identified two spliced epitopes within the secreted bacterial phospholipase PlcB that primed antigen-specific CD8 + T cells in L. monocytogenes -infected mice. While reacting to the spliced epitopes, these CD8 + T cells failed to recognize the non-spliced peptide parts in the context of their natural flanking sequences. Thus, we here show that PCPS expands the CD8 + T cell response against L. monocytogenes by exposing spliced epitopes on the cell surface. Moreover, our multi-level strategy opens up opportunities to systematically investigate proteins for spliced epitope candidates and thus strategies for immunotherapies or vaccine design.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Platteel et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: